105 related articles for article (PubMed ID: 35641278)
1. Adverse Cardiovascular Effects of Anti-tumor Therapies in Patients With Breast Cancer: A Single-center Cross-sectional Analysis.
Rosenkaimer S; Sieburg T; Winter L; Mavratzas A; Hofmann WK; Hofheinz RD; Akin I; Duerschmied D; Hohneck A
Anticancer Res; 2022 Jun; 42(6):3075-3084. PubMed ID: 35641278
[TBL] [Abstract][Full Text] [Related]
2. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.
Houbois CP; Nolan M; Somerset E; Shalmon T; Esmaeilzadeh M; Lamacie MM; Amir E; Brezden-Masley C; Koch CA; Thevakumaran Y; Yan AT; Marwick TH; Wintersperger BJ; Thavendiranathan P
JACC Cardiovasc Imaging; 2021 May; 14(5):962-974. PubMed ID: 33248962
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights.
Shibata T; Nohara S; Morikawa N; Shibao K; Ito S; Shibata R; Toh U; Nagafuji K; Fukami K; Fukumoto Y
Eur J Prev Cardiol; 2023 Dec; 30(18):1941-1949. PubMed ID: 37352112
[TBL] [Abstract][Full Text] [Related]
4. Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction.
Hussain Y; Drill E; Dang CT; Liu JE; Steingart RM; Yu AF
Breast Cancer Res Treat; 2019 May; 175(1):239-246. PubMed ID: 30721443
[TBL] [Abstract][Full Text] [Related]
5. Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study.
Gong IY; Ong G; Brezden-Masley C; Dhir V; Deva DP; Chan KKW; Graham JJ; Chow CM; Thavendiranathan P; Dai D; Ng MY; Barfett JJ; Connelly KA; Yan AT
Int J Cardiovasc Imaging; 2019 Apr; 35(4):653-662. PubMed ID: 30390170
[TBL] [Abstract][Full Text] [Related]
6. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.
Drafts BC; Twomley KM; D'Agostino R; Lawrence J; Avis N; Ellis LR; Thohan V; Jordan J; Melin SA; Torti FM; Little WC; Hamilton CA; Hundley WG
JACC Cardiovasc Imaging; 2013 Aug; 6(8):877-85. PubMed ID: 23643285
[TBL] [Abstract][Full Text] [Related]
7. Effect of Rosuvastatin in Preventing Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer: A Randomized, Single-Blind, Placebo-Controlled Trial.
Nabati M; Janbabai G; Esmailian J; Yazdani J
J Cardiovasc Pharmacol Ther; 2019 May; 24(3):233-241. PubMed ID: 30599756
[TBL] [Abstract][Full Text] [Related]
8. Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer.
Basser RL; Abraham R; To LB; Fox RM; Green MD
Ann Oncol; 1999 Jan; 10(1):53-8. PubMed ID: 10076722
[TBL] [Abstract][Full Text] [Related]
9. Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.
Yu AF; Mukku RB; Verma S; Liu JE; Oeffinger KC; Steingart RM; Hudis CA; Dang CT
Breast Cancer Res Treat; 2017 Nov; 166(1):241-247. PubMed ID: 28710537
[TBL] [Abstract][Full Text] [Related]
10. Echocardiographic Predictors of Mortality in Women With Heart Failure With Reduced Ejection Fraction.
Lundorff IJ; Sengeløv M; Godsk Jørgensen P; Pedersen S; Modin D; Eske Bruun N; Fritz-Hansen T; Skov Jensen J; Biering-Sørensen T
Circ Cardiovasc Imaging; 2018 Nov; 11(11):e008031. PubMed ID: 30571317
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Power Output Is Independently and Incrementally Associated With Adverse Outcomes in Heart Failure With Preserved Ejection Fraction.
Harada T; Yamaguchi M; Omote K; Iwano H; Mizuguchi Y; Amanai S; Yoshida K; Kato T; Kurosawa K; Nagai T; Negishi K; Anzai T; Obokata M
Circ Cardiovasc Imaging; 2022 Feb; 15(2):e013495. PubMed ID: 35144484
[TBL] [Abstract][Full Text] [Related]
12. Reliability of Left Ventricular Ejection Fraction from Three-Dimensional Echocardiography for Cardiotoxicity Onset Detection in Patients with Breast Cancer.
Lorenzini C; Lamberti C; Aquilina M; Rocca A; Cortesi P; Corsi C
J Am Soc Echocardiogr; 2017 Nov; 30(11):1103-1110. PubMed ID: 28822666
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Right Ventricular Dysfunction in Heart Failure With Reduced Ejection Fraction: Superiority of Longitudinal Strain Over Tricuspid Annular Plane Systolic Excursion.
Carluccio E; Biagioli P; Alunni G; Murrone A; Zuchi C; Coiro S; Riccini C; Mengoni A; D'Antonio A; Ambrosio G
Circ Cardiovasc Imaging; 2018 Jan; 11(1):e006894. PubMed ID: 29321212
[TBL] [Abstract][Full Text] [Related]
14. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the long term cardiac effects associated with 9 and 52 weeks of trastuzumab in HER2-positive early breast cancer.
Şendur MA; Aksoy S; Yorgun H; Ozdemir N; Yilmaz FM; Yazıcı O; Zungun C; Aytemir K; Zengin N; Altundag K
Curr Med Res Opin; 2015 Mar; 31(3):547-56. PubMed ID: 25586297
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction.
Hensen LCR; Goossens K; Delgado V; Abou R; Rotmans JI; Jukema JW; Bax JJ
Eur J Heart Fail; 2018 Mar; 20(3):560-568. PubMed ID: 29164753
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular end-diastolic volume as early indicator of trastuzumab-related cardiotoxicity in HER2+ breast cancer patients: results from a single-center retrospective study.
Bergamini C; Torelli F; Ghiselli L; Rossi A; Trevisani L; Vinco G; Truong S; Benfari G; LA Russa F; Golia G; Molino A; Vassanelli C
Minerva Cardioangiol; 2017 Jun; 65(3):278-287. PubMed ID: 27886160
[TBL] [Abstract][Full Text] [Related]
19. Right ventricular global longitudinal strain provides prognostic value incremental to left ventricular ejection fraction in patients with heart failure.
Motoki H; Borowski AG; Shrestha K; Hu B; Kusunose K; Troughton RW; Tang WH; Klein AL
J Am Soc Echocardiogr; 2014 Jul; 27(7):726-32. PubMed ID: 24679740
[TBL] [Abstract][Full Text] [Related]
20. Right Ventricular Function in Peripartum Cardiomyopathy at Presentation Is Associated With Subsequent Left Ventricular Recovery and Clinical Outcomes.
Blauwet LA; Delgado-Montero A; Ryo K; Marek JJ; Alharethi R; Mather PJ; Modi K; Sheppard R; Thohan V; Pisarcik J; McNamara DM; Gorcsan J;
Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
